This Quebec man is losing his voice. An AI tool is helping bring it back to life
"It's pretty dramatic," said Cooper, backing away from the microphone and letting out a laugh.
"I just realized, my God, it really is talking about death."
It's a subject Cooper says he's been forced to think about over the past year and a half after he was diagnosed with ALS, a terminal motor neuron disease. He was initially given an average life expectancy of two to five years.
The family doctor, originally from Victoria, had 1,800 patients before announcing his snap retirement last year.
Staying busy renovating his house to become wheelchair accessible, Cooper has also been spending more time in front of a microphone — recording common sayings, elaborate poems and his favourite book passages as part of the process to clone his voice for when the disease progresses further.
He's using AI-powered voice technology by ElevenLabs — a U.S.-based company that is offering the tech to one million people who suffer from degenerative diseases, including ALS, mouth cancer, stroke victims or those with Parkinson's disease.
The AI tool allows users to input a small amount of audio which generates a voice clone with that person's natural tone and inflection when they need to rely on text-to-speech devices. Cooper started feeding the ElevenLabs bank himself at home and is getting help from professionals at the local rehab centre.
"When the voice is gone, it's gone forever," said Cooper.
"Thanks to this technology, the disease can't take my voice away."
'Facing it with tremendous courage'
Compared to most people who have an ALS diagnosis, Cooper says he's considered a "slow progressor" and that he looks "pretty bloody good."
Still, the symptoms of the illness are creeping up. He says he's starting to have trouble dressing, doing up buttons and handling utensils.
His friend, Dr. Jean-Pierre Canuel, who was diagnosed with ALS 11 years ago, is further along.
Canuel, a retired doctor, still gardens using his lawn mower, drives an adapted van and is dedicated to his hobby of making wooden charcuterie boards.
Sitting in his motorized wheelchair, he smiles while swiping through photos of his grandchildren. It takes great effort to speak, but Canuel tells CBC that before his diagnosis, "I was a strong man."
He did not have the opportunity to record his voice before his speech became severely impacted by the disease. Canuel burst into tears as Cooper greeted him in the recording area in Quebec City on a humid morning at the end of June.
"It's taken his voice away, which happens to all of us," said Cooper, resting his hand on Canuel's back, consoling him.
"He's facing it with tremendous courage."
It's an approach Cooper is trying to adopt, he says, taking all the advice and inspiration from Canuel as possible.
"I'll get all misty-eyed again, but Jean-Pierre is an incredibly courageous person. That's the way I want to be," he said, breaking down.
"You have to kind of embrace it and not deny it."
Improving quality of life
AI voice cloning is relatively new, says Dr. Angela Genge, head of the ALS Centre of Excellence at the Montreal Neurological Institute. She says until the past decade, it wasn't widely available to patients.
But multidisciplinary clinics can now offer patients voice banking relatively early on in their diagnosis, she says.
"It makes a big difference for them," said Genge, a professor at McGill University. "I see AI helping with quality of life and I think it's fairly significant."
She says she's used to hearing computer-generated voices articulating what patients want to say. Before the "computer age," she says patients were limited to talking using pointing cards.
Now, when the disease progresses to the point of impacting speech, a patient can be equipped with devices which can formulate words and sentences in their own voice, says Sophie Dupont, a speech language pathologist for the local health authority working at the Institut de réadaptation en déficience physique de Québec.
"When we're talking about text, you're literally going to be typing first [on a tablet] if you are still able," she said.
The tool can also be adjusted to be used through eye control or head tracking, much like the speech-generating device used by renowned physicist Stephen Hawking, who had ALS, Dupont says.
Usually, when patients arrive in her office, their ability to speak is already impaired, she says. In these cases, she relies on recordings or voicemails to power an AI voice.
Having worked with Cooper for the past six months, Dupont says the AI tool is used on an exceptional basis. She says she has to balance the urgency of patients' needs with current resources.
'It's going to be a legacy'
Traditionally, robotic voices available for ALS patients didn't come in all shapes and sizes, says Dustin Blank, based in Los Angeles, who leads partnerships at ElevenLabs.
"Now every dialect, every language … it sounds like yourself," he said.
"It is how they spoke in that same cadence, in that same emotion. And that's super powerful."
He says the company's impact program is hoping to find ways to get their voice technology into the hands of people who need it most.
With concerns regarding the power and security of AI, he says the company understands that voices, and the process of cloning them, are "powerful things."
Taking steps to protect people's voices with password protection and voice verification, the company takes safety "very seriously," he says.
Sylvie Barma, Cooper's wife of 30 years, says this tool is proof that AI is "not only bad things."
While her husband is enjoying the process of using the AI tool, for Barma, the recording process is a reminder of the reality of the disease and the challenges the couple is bound to face as Cooper's health deteriorates.
When she overhears him recording at home, Barma says she steps out into her sanctuary — her garden.
"I just move away," she says. "We know it's coming, but I prefer not to think too much ahead.
"It's going to be a legacy."

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Washington Post
43 minutes ago
- Washington Post
Asking Eric: After ugly comments, brother invites himself to party
Dear Eric: Nearly eight months ago, my 81-year-old brother lashed out saying hateful and hurtful things about our youngest sister. At the time, I suspected he was drunk and probably frustrated from the repeated episodes of our sister's illnesses and problems, some of which have been caused by her own serious eating disorder, depression and occasional binge drinking.
Yahoo
an hour ago
- Yahoo
Maximise Your Portfolio's Returns with These 3 US Healthcare Stocks
With persistent macro uncertainty and shifting market trends, healthcare remains one of the most defensive and fundamentally sound sectors for investors. The US healthcare industry continues to deliver both stability and long-term growth potential. In the latter half of 2025, these three healthcare stocks emerge as top picks for their compelling mix of innovation and favourable industry trends. Johnson & Johnson (J&J) is a global healthcare company with its core businesses in innovative medicine and MedTech. In the first quarter of 2025 (1Q 2025), J&J reported 2.4% year-on-year (YoY) increase in revenue, bringing in US$21.9 billion. This growth can be attributed to a strong revenue growth of 4.2% YoY in innovative medicine. A key driver for the rise is the 20.4% YoY in revenue growth in the oncology segment. This increase is due to medicine such as DARZALEX and ERLEADA experiencing share gains amid market growth.J&J's MedTech division recorded a strong 4.1% YoY revenue growth. The cardiovascular segment led this jump in revenue with a 17% YoY revenue growth. This growth is due to strong global procedure volumes and successful new product launches. The firm's internal forecast for sales of its key products by 2027/2028 is also higher than current market estimates. For instance, its pipeline product, the intravesical drug releasing system, is forecasted to have three times the product sales compared to current market estimates by 2027/ presents an opportunity for investors to capitalise on the potential upside which is not yet priced into the stock. This upside will be driven by J&J's internal forecasts, which signal confidence in its operations. Thermo Fisher is a top name in biopharmaceutical research, particularly in drug discovery and 1Q 2025, Thermo Fisher reported revenue of US$10.36 billion, along with organic revenue growth of 1% YoY. The firm's net profits climbed 13.5% YoY to US$1.5 billion in 1Q 2025. This strong growth was supported by the increased operational efficiencies with the partnership with the Chan Zuckerberg Institute for Advanced Biological partnership pioneers new technologies for improved human cell visualisation, providing scientists with better data insights and accelerating research cycles. In February 2025, Thermo Fisher also announced a US$4.1 billion acquisition of Solventum's Purification & Filtration Purification & Filtration business offerings enhance Thermo Fisher's current bioproduction services. This acquisition boosts Thermo Fisher's biologics production capabilities, thereby improving productivity. This deal also opens opportunities to cross-sell filtration and purification solutions alongside existing bioprocessing offerings. These developments demonstrate an effective strategic fit and may result in service margin expansion. UnitedHealth Group runs two primary businesses – UnitedHealthcare for healthcare insurance plans and Optum for technology-based healthcare services. UnitedHealth Group reported a 9.8% YoY increase in revenue in 1Q 2025, reaching US$109.6 billion. The company's net margin also improved to 5.7% in the same quarter. The previous year's quarter saw a net loss margin of 1.4%. The better performance was attributed to a strong performance for both UnitedHealthcare and Optum. In 1Q 2025, UnitedHealthcare's revenue grew by 12.2% YoY to US$84.6 billion. This growth was driven by a rise of 700,000 in the number of self-funded commercial plans sold. Another factor was the increased participation in senior and community-based offerings with 545,000 new members. In the same period, Optum saw an increase in revenue of 4.6% YoY to US$63.9 billion. This rise is led by a growth of Optum Rx which had an increase of 13 million scripts from new clients and deepening of existing relationships compared to 2024. Optum Insight also introduced artificial intelligence claim processing tools which increase productivity by over 20%. Moving forward, Optum Health announced its continued expansion of value-based care to serve 650,000 new patients in 2025. As the healthcare landscape transforms, these three companies offer stand-out opportunities amid uncertain markets. With these companies' blend of innovation and strong fundamentals, they provide a defensive anchor along with room for growth. These three stocks are well-positioned to deliver meaningful returns. It's a good idea to consider adding this trio into your buy watchlist of growth stocks. Generative AI is reshaping the stock market, but not in the way most investors think. It's not just about which companies are using AI. It's about how they're using it to unlock new revenue, dominate their markets, and quietly reshape the business world. Our latest FREE report 'How GenAI is Reshaping the Stock Market' breaks the hype down, so you can invest with greater clarity and confidence. Click here to download your copy today. Follow us on Facebook, Instagram and Telegram for the latest investing news and analyses! Disclosure: Gabriel Lim does not own shares in any of the companies mentioned. The post Maximise Your Portfolio's Returns with These 3 US Healthcare Stocks appeared first on The Smart Investor. Sign in to access your portfolio


CBS News
3 hours ago
- CBS News
Detecting, monitoring skin cancers made easier with new screening technology
According to the American Cancer Society, more than 100,000 people will be diagnosed with melanoma this year. The good news is now that treatments have advanced, death rates have declined. Diagnostic tools have also vastly improved to detect and monitor skin cancers. Vectra WB180 system takes just seconds to photograph spots Dr. Jonathan Unger, medical director of the Waldman Melanoma and Skin Cancer Center at Mount Sinai, showed CBS News New York the Vectra WB180 system. "Basically, it is a total body photography system," Unger said. "We use 26 cameras to photograph the entire body ... And then the system takes all of these photos, high-resolution photos, and stitches them together into a three-dimensional avatar." The Vectra WB180 system uses 26 cameras to photograph the entire body so doctors can monitor spots on patients' skin. CBS News New York This is relatively new screening technology with about 100 machines across the country. Unger says it takes just a matter of seconds instead of all the time necessary to photograph each individual spot. "Gives us a memory of every spot on the patient's body, right? Once we have a moment in time, we can always look back and say, what did this thing look like? Was it there? Was it not there? Has it been changing?" he said. He adds accessing details of a patient's mole is much quicker, again, taking only seconds. There are additional benefits to this technology, as well. "Decide with greater certainty and more information whether something needs to be checked, tested, biopsied, et cetera," he said. "In our practice, it's really reduced the number of biopsies because a lot of our patients have hundreds, if not more than that, moles, all of which are irregular." He continued, "This allows us to have a higher level of confidence about what we're looking at and making a decision about." "It gives me the ability to take a deep breath and enjoy my life" Patient Jackie Mills has her spots scrutinized with the new machine after a scare several years ago. "In about 2020, I noticed a spot on my face that was new and rapidly changing," she said. But Mills says her dermatologist at that time wasn't that concerned. "I felt like it was getting bigger, changing colors, it was more jagged, and I really had to push and advocate for myself," she said. "Just had a gut feeling that something was wrong, and I was right." Mills was finally diagnosed with melanoma and had Mohs surgery to have the spot removed. "I had to kind of take it in for a minute and be like, I'm going to have a scar on my face for the rest of my life," she said. "It was that or not be here." Now she's checked every six months. "Not only is Dr. Unger looking at my spots, but he's using this machine to mathematically track what's going on from year to year. And I think that's just, it gives me the ability to take a deep breath and enjoy my life and not be constantly worried about melanoma coming back or being an issue," Mills said. The biggest safety tip from doctors is to use sunscreen every day. It can help prevent sunburn, premature aging and skin cancer.